Related Experiment Video

Updated: May 8, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Improving disease burden in myelofibrosis: changing the natural history of the disease

Ruben A Mesa1

  • 1Acute and Chronic Leukemias Program, Division of Hematology-Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona, USA.

Oncology (Williston Park, N.Y.)
|August 28, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Related Experiment Videos

Last Updated: May 8, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Articles linked to this work by shared authors, journal, and citation graph.

Exposure-Response Analyses of Ropeginterferon Alfa-2b in Essential Thrombocythemia.

Journal of clinical pharmacology·2026

Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026.

Current hematologic malignancy reports·2026

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Blood·2026

Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).

Lancet regional health. Americas·2026

Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer.

JCO oncology practice·2026

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

Blood advances·2026

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.

Oncology (Williston Park, N.Y.)·2026

Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.

Oncology (Williston Park, N.Y.)·2026

Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.

Oncology (Williston Park, N.Y.)·2026

Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026

Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.

Oncology (Williston Park, N.Y.)·2026

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026

Two-Port Endoscopic Left Atrial Myxoma Resection Under Ventricular Fibrillation Without Aortic Cross-Clamping.

JACC. Case reports·2026

Real-Time Hemodynamic Guidance During Valve-in-Valve TAVI.

JACC. Case reports·2026

Isoalantolactone exhibits activity against Echinococcus multilocularis associated with mitochondrial perturbation and changes in the lesion microenvironment.

Frontiers in pharmacology·2026

From Physiological Spaces to Cognitive Health: A New Perspective on Combined Acupuncture and Chinese Herbal Medicine for Alzheimer's Disease.

Research (Washington, D.C.)·2026

Case Report: Distal ureteral obstruction decades after presumed intrauterine device removal in a woman with uterus didelphys.

Frontiers in medicine·2026

Erratum: Genome-wide target interactome profiling reveals a novel EEF1A1 epigenetic pathway for oncogenic lncRNA MALAT1 in breast cancer.

American journal of cancer research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us